Medical Research
(H9B)
INTERNATIONAL CELL SURGICAL SOCIETY
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2023
$301K
Total Revenue
$319K
Total Expenses
$-231,008
Net Assets
0
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
96.3%
Fundraising Efficiency
0.0%
Operating Reserve
-8.69x
Liability-to-Asset
185.9%
Revenue Diversification
100.0%
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2023 | $301K | $319K | $-231,008 | 96.3% | 0 |
| 2022 | $224K | $323K | N/A | — | 0 |
| 2021 | $310K | $295K | N/A | — | 0 |
Donor Reviews
No reviews yet
Be the first to share your experience with this organization.